GHM Stock Analysis: Graham | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 1.349m USD | 12M Return: 103% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 32.7M
EPS Trend: 95.7%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Graham Corporation (NYSE: GHM) is a U.S.-based industrial machinery company that designs and manufactures fluid, power, heat transfer, and vacuum technologies for a diverse set of end markets, including chemical and petrochemical processing, defense, space, petroleum refining, cryogenic, and energy. The company is headquartered in Batavia, New York, was founded in 1936, and operates across the United States, Asia, Canada, the Middle East, South America, and other international markets.
Its product portfolio spans power plant systems (ejectors and surface condensers), torpedo ejection, propulsion and power systems (turbines, alternators, regulators, pumps, and blowers), heat transfer and vacuum systems (ejectors, condensers, liquid ring pumps, heat exchangers, and nozzles), power generation systems (turbines, generators, compressors, and pumps), and thermal management systems. For the space industry, Graham supplies rocket propulsion systems (turbopumps and propellant pumps), cooling systems, and life support systems, while also selling and servicing spare parts across its installed base.
As a small-cap industrial machinery business, Graham operates as a B2B supplier of engineered, mission-critical components, with its defense and space exposure typically providing multi-year program visibility and its commercial/energy business tied to capital spending cycles in refining, petrochemicals, and power generation.
- Defense thermal management and propulsion backlog expands
- Rocket turbopump demand surges with commercial space launches
- Petrochemical and refining capex drives heat transfer orders
| Net Income: 12.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -2.07 > 1.0 |
| NWC/Revenue: 0.81% < 20% (prev 2.49%; Δ -1.68% < -1%) |
| CFO/TA 0.05 > 3% & CFO 15.9m > Net Income 12.5m |
| Net Debt (19.0m) to EBITDA (22.7m): 0.84 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.1m) vs 12m ago 0.21% < -2% |
| Gross Margin: 23.54% > 18% (prev 25.18%; Δ -1.64% > 0.5%) |
| Asset Turnover: 83.47% > 50% (prev 79.47%; Δ 4.00% > 0%) |
| Interest Coverage Ratio: 20.77 > 6 (EBIT TTM 14.8m / Interest Expense TTM 713k) |
| A: 0.01 (Total Current Assets 156.5m - Total Current Liabilities 154.5m) / Total Assets 323.6m |
| B: 0.33 (Retained Earnings 106.7m / Total Assets 323.6m) |
| C: 0.05 (EBIT TTM 14.8m / Avg Total Assets 293.9m) |
| D: 0.77 (Book Value of Equity 140.3m / Total Liabilities 183.3m) |
| Altman-Z'' = 2.26 = BBB |
| DSRI: 1.06 (Receivables 93.7m/75.5m, Revenue 245.3m/209.9m) |
| GMI: 1.07 (GM 25.18% / 23.54%) |
| AQI: 1.24 (AQ_t 0.31 / AQ_t-1 0.25) |
| SGI: 1.17 (Revenue 245.3m / 209.9m) |
| TATA: -0.01 (NI 12.5m - CFO 15.9m) / TA 323.6m) |
| Beneish M = -2.65 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 106.65 with a total of 164,734 shares traded. Over the past week, the price has changed by -13.85%, over one month by +11.86%, over three months by +19.06% and over the past year by +103.03%.
Current recommended Stop Loss: 97.90 (which is 8.2% or 1.3 ATR below the current price).
Graham has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy GHM.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 130.8 | 22.6% |
P/E Trailing = 103.0536
P/E Forward = 58.8235
P/S = 5.4925
P/B = 9.6169
P/EG = 3.2632
Revenue TTM = 245.3m USD
EBIT TTM = 14.8m USD
EBITDA TTM = 22.7m USD
Long Term Debt = 13.0m USD (from longTermDebt, last quarter)
Short Term Debt = 23.0k USD (from shortTermDebt, last quarter)
Debt = 25.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 7.19m
Net Debt = 19.0m USD (calculated: Debt 25.6m - CCE 6.58m)
Enterprise Value = 1.37b USD (1.35b + Debt 25.6m - CCE 6.58m)
Interest Coverage Ratio = 20.77 (Ebit TTM 14.8m / Interest Expense TTM 713k)
EV/FCF = -1000.0x (Enterprise Value 1.37b / FCF TTM -121k)
FCF Yield = -0.01% (FCF TTM -121k / Enterprise Value 1.37b)
FCF Margin = -0.05% (FCF TTM -121k / Revenue TTM 245.3m)
Net Margin = 5.10% (Net Income TTM 12.5m / Revenue TTM 245.3m)
Gross Margin = 23.54% ((Revenue TTM 245.3m - Cost of Revenue TTM 187.5m) / Revenue TTM)
Gross Margin QoQ = 23.39% (prev 22.99%)
Tobins Q-Ratio = 4.23 (Enterprise Value 1.37b / Total Assets 323.6m)
Interest Expense / Debt = 2.79% (Interest Expense 713k / Debt 25.6m)
Taxrate = 11.32% (1.60m / 14.1m)
NOPAT = 13.1m (EBIT 14.8m * (1 - 11.32%))
Current Ratio = 1.01 (Total Current Assets 156.5m / Total Current Liabilities 154.5m)
Debt / Equity = 0.18 (Debt 25.6m / totalStockholderEquity, last quarter 140.3m)
Debt / EBITDA = 0.84 (Net Debt 19.0m / EBITDA 22.7m)
Debt / FCF = -157.0 (out of range, set to none) (Net Debt 19.0m / FCF TTM -121k)
Total Stockholder Equity = 130.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 12.5m / Total Assets 323.6m)
RoE = 9.57% (Net Income TTM 12.5m / Total Stockholder Equity 130.6m)
RoCE = 10.31% (EBIT 14.8m / Capital Employed (Equity 130.6m + L.T.Debt 13.0m))
RoIC = 8.08% (NOPAT 13.1m / Invested Capital 162.6m)
WACC = 12.00% (E(1.35b)/V(1.37b) * Re(12.18%) + D(25.6m)/V(1.37b) * Rd(2.79%) * (1-Tc(0.11)))
Discount Rate = 12.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 0.88%
[DCF] Fair Price = unknown (Cash Flow -121k)
EPS Correlation: 95.68 | EPS CAGR: 119.1% | SUE: 0.39 | # QB: 0
Revenue Correlation: 99.37 | Revenue CAGR: 14.39% | SUE: 2.00 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.37 | Chg30d=-18.68% | Revisions=+25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.51 | Chg30d=-8.18% | Revisions=+25% | Analysts=4
EPS current Year (2027-03-31): EPS=1.84 | Chg30d=-7.29% | Revisions=-40% | GrowthEPS=+31.8% | GrowthRev=+17.9%
EPS next Year (2028-03-31): EPS=2.25 | Chg30d=-4.15% | Revisions=+0% | GrowthEPS=+22.1% | GrowthRev=+11.3%
[Analyst] Revisions Ratio: +0% (up=2, down=2)